Mark Smyth

Mark Smyth (FAA, FAHMS) is a Senior Scientist and Immunology Coordinator at QIMR Berghofer Medical Research Institute. He completed his PhD in 1988 and trained at the National Cancer Institute in the USA (1988-1992), before commencing his independent research career in Australia. Over the last 20 years he rekindled world-wide interest in cancer immune surveillance, defined immune-mediated dormancy of cancer, and the role of host immunity in chemotherapy and targeted therapy responses. More recently, he has provided new means of classifying natural killer cell (NK) subtypes and three new targets for cancer immunotherapy.

Professor Smyth is a past winner of the Coley Medal and Brupbacher Foundation Prizes in Cancer Research. He is the highest cited immunologist in Australia and is a Senior Editor, and Advisory Board Member for Cancer Immunology Research and Science, respectively.

Mark Smyth appears with thanks to Program Partner QIMR Berghofer Medical Research Institute.